The main difference between going public through an initial public offering (IPO) and staying private lies in ownership ...
Investment bankers are gearing up for a pickup in dealmaking activity in global equity capital markets this year, buoyed by a ...
Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...
Beta Bionics is commercializing innovative insulin delivery technologies, but faces challenges in achieving profitability.
Phaos Technology Holdings' IPO is excessively priced, with significant risks and a small revenue base. Explore more details ...
IPO GMP News Highlights (January 9): The allotment of shares for the Standard Glass Lining Technology IPO is expected to be ...
Analysts believe the resilience of the broader IPO market is intact with the momentum witnessed in 2024 expected to extend into 2025. Narendra Solanki, Head of Fundamental Research - Investment ...